Which has the lower trailing P/E, KR or MEDP?

KR has the lower trailing P/E: KR trades at 33.91 and MEDP at 34.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, KR or MEDP?

Over the past five years, MEDP grew revenue faster — KR at a 2.33% CAGR versus MEDP at 22.03%.

Does KR or MEDP pay a bigger dividend?

KR pays a dividend (2.41% yield), while MEDP has no payments in the available dividend history.

Is KR or MEDP more profitable?

MEDP runs the higher net margin — KR at 0.71% versus MEDP at 17.67%.

How have KR and MEDP total returns compared?

Over the past 5 years, KR delivered 7.90% and MEDP delivered 28.06% annualized total return. Past performance doesn't predict future results.

The Kroger Co. (KR) vs Medpace Holdings, Inc. (MEDP)

A side-by-side comparison of The Kroger Co. and Medpace Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Different business models: KR is classified in Consumer Defensive; MEDP is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

The Kroger Co.

$36.26B

$59.19Consumer DefensiveDelayed quote: Jul 28, 2026, 4:00 PM EDT

MEDP

Medpace Holdings, Inc.

$15.94B

$570.97HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — KR vs MEDP

growth of $100 · dividends reinvested · last 10y

KR +114.2%MEDP +2020.8%MEDP compounded faster

Log scale — wide-divergence pair

KR MEDP

KR vs MEDP: by the numbers

•KR is the larger company ($36.26B vs $15.94B market cap).
•KR trades at the lower trailing earnings multiple (33.91 vs 34.53 P/E), one valuation lens rather than an overall verdict.
•MEDP converts more revenue to profit (17.67% vs 0.71% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 2.33% CAGR).
•KR pays a dividend (2.41% yield), while MEDP has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	KR	MEDP
P/E ratio	33.91	34.53
Forward P/E	12.07	33.60
P/S ratio	0.24	6.09
P/B ratio	5.51	39.07
PEG ratio	N/A	1.82
EV / EBITDA	10.44	27.73
FCF yield	8.09%	4.51%

Profitability

Metric	KR	MEDP
Gross margin	23.18%	28.76%
Operating margin	1.33%	20.97%
Net margin	0.71%	17.67%
ROE	16.27%	113.29%
ROIC	4.70%	67.94%

Dividends

Metric	KR	MEDP
Dividend yield	2.41%	N/A
Payout ratio	89.74%	N/A

Growth (annualized)

Metric	KR	MEDP
Revenue CAGR (5Y)	2.33%	22.03%
EPS CAGR (5Y)	-13.96%	30.90%
FCF CAGR (5Y)	-1.62%	24.42%
Total return CAGR (5Y)	10.73%	28.06%

Frequently asked

Which has the lower trailing P/E, KR or MEDP?: KR has the lower trailing P/E: KR trades at 33.91 and MEDP at 34.53. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, KR or MEDP?: Over the past five years, MEDP grew revenue faster — KR at a 2.33% CAGR versus MEDP at 22.03%.
Does KR or MEDP pay a bigger dividend?: KR pays a dividend (2.41% yield), while MEDP has no payments in the available dividend history.
Is KR or MEDP more profitable?: MEDP runs the higher net margin — KR at 0.71% versus MEDP at 17.67%.
How have KR and MEDP total returns compared?: Over the past 5 years, KR delivered 7.90% and MEDP delivered 28.06% annualized total return. Past performance doesn't predict future results.

Go deeper

Full KR analysis Full MEDP analysis Interactive comparison tool

Dig into the metrics

Kroger P/E ratio Medpace P/E ratio Kroger dividend yield Medpace dividend yield Kroger ROE Medpace ROE Kroger operating margin Medpace operating margin Kroger revenue growth Medpace revenue growth Kroger free cash flow Medpace free cash flow

Kroger & Medpace appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.